1481 related articles for article (PubMed ID: 17063274)
1. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the role of dynamic contrast-enhanced MR imaging for patients with BI-RADS 3-4 microcalcifications.
Jiang Y; Lou J; Wang S; Zhao Y; Wang C; Wang D
PLoS One; 2014; 9(6):e99669. PubMed ID: 24927476
[TBL] [Abstract][Full Text] [Related]
4. Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.
Linda A; Zuiani C; Londero V; Di Gaetano E; Dal Col A; Girometti R; Bazzocchi M
Radiol Med; 2014 Jun; 119(6):393-9. PubMed ID: 24297595
[TBL] [Abstract][Full Text] [Related]
5. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
7. The value of breast MRI for BI-RADS category 4B mammographic microcalcification: based on the 5
Eun NL; Son EJ; Gweon HM; Youk JH; Kim JA
Clin Radiol; 2018 Aug; 73(8):750-755. PubMed ID: 29853301
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the diagnostic value of contrast-enhanced breast MR imaging and mammography on patients with BI-RADS 3-5 microcalcifications.
Li E; Li J; Song Y; Xue M; Zhou C
PLoS One; 2014; 9(11):e111217. PubMed ID: 25365327
[TBL] [Abstract][Full Text] [Related]
9. Usefulness and limitations of the Japan Mammography Guidelines for the categorization of microcalcifications.
Uematsu T; Kasami M; Yuen S
Breast Cancer; 2008; 15(4):291-7. PubMed ID: 18288569
[TBL] [Abstract][Full Text] [Related]
10. The value of dynamic contrast enhanced breast MRI in mammographically detected BI-RADS 5 microcalcifications.
Houserkova D; Prasad SN; Svach I; Kucerova L; Duskova M; Bucil J; Sisola I; Zlamalova N; Svebisova H
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):107-15. PubMed ID: 18795084
[TBL] [Abstract][Full Text] [Related]
11. [Stereotactic vacuum-assisted breast biopsy--success, histologic accuracy, patient acceptance and optimizing the BI-RADSTM-correlated indication].
Siegmann KC; Wersebe A; Fischmann A; Fersis N; Vogel U; Claussen CD; Müller-Schimpfle M
Rofo; 2003 Jan; 175(1):99-104. PubMed ID: 12525989
[TBL] [Abstract][Full Text] [Related]
12. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
13. MRI and comparison mammography: a worthy diagnostic alliance for breast microcalcifications?
Brnic D; Brnic D; Simundic I; Vanjaka Rogosic L; Tadic T
Acta Radiol; 2016 Apr; 57(4):413-21. PubMed ID: 25995311
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice.
Mendez A; Cabanillas F; Echenique M; Malekshamran K; Perez I; Ramos E
Cancer; 2004 Feb; 100(4):710-4. PubMed ID: 14770425
[TBL] [Abstract][Full Text] [Related]
15. Breast 3 T-MR imaging: indication for stereotactic vacuum-assisted breast biopsy.
Yamamoto N; Yoshizako T; Yoshikawa K; Itakura M; Maruyama R; Kitagaki H
Springerplus; 2014; 3():481. PubMed ID: 25932356
[TBL] [Abstract][Full Text] [Related]
16. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).
Tsuchiya K; Mori N; Schacht DV; Sheth D; Karczmar GS; Newstead GM; Abe H
J Magn Reson Imaging; 2017 Dec; 46(6):1738-1747. PubMed ID: 28295791
[TBL] [Abstract][Full Text] [Related]
17. Positive predictive value of BI-RADS MR imaging.
Mahoney MC; Gatsonis C; Hanna L; DeMartini WB; Lehman C
Radiology; 2012 Jul; 264(1):51-8. PubMed ID: 22589320
[TBL] [Abstract][Full Text] [Related]
18. MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
Bennani-Baiti B; Dietzel M; Baltzer PA
PLoS One; 2017; 12(11):e0188679. PubMed ID: 29190656
[TBL] [Abstract][Full Text] [Related]
19. The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories.
Bent CK; Bassett LW; D'Orsi CJ; Sayre JW
AJR Am J Roentgenol; 2010 May; 194(5):1378-83. PubMed ID: 20410428
[TBL] [Abstract][Full Text] [Related]
20. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
Friedlander LC; Roth SO; Gavenonis SC
Radiology; 2011 Nov; 261(2):421-7. PubMed ID: 21900618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
